Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.
NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.
Sieber Direct Communications At NCI, Reorganizing Offices.
“5 A Day” Review Underway to Check Program’s Health at NCI.
AACR Honors Nine Cancer Researchers, Clinicians.
Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.
FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.
Bristol-Myers, Karolinska In Collaboration For Studies.
Antigenics Begins Phase II Trial Of Oncophage for NHL.
Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS
RFP: Intellectual Property.
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Scaling excellence: How City of Hope is transforming cancer care delivery
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI
